Blood in joint (hemarthrosis)
Also known as: Hemarthrosis
Methodology & AI Transparency ⓘ
Blood in joint (hemarthrosis) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Blood in joint (hemarthrosis) (also termed Hemarthrosis) is an ICD-10-CM indexed diagnosis (M25.00) within Osteoarthritis, Gout & Joint Pain.
- 2 Real-world patient consensus: Synonyms for Blood in joint (hemarthrosis) (M25.00): Hemarthrosis (Arthritis & Joints).
- 3 Typical cash cost range: Clinicians assessing Blood in joint (hemarthrosis) focus on subchondral bone remodeling [Blood in joint (hemarthrosis) M25.00] and targeted history.
- 4 Top reported side effects / signs: Follow-up benchmark in Blood in joint (hemarthrosis): maintaining Weight-Bearing Joint Radiograph [Blood in joint (hemarthrosis) M25.00] within Preserved joint-space width (M25.00).
Ask our AI Specialists anything about Blood in joint (hemarthrosis)
What Is Blood in joint (hemarthrosis)?
Blood in joint (hemarthrosis) (also termed Hemarthrosis) is an ICD-10-CM indexed diagnosis (M25.00) within Osteoarthritis, Gout & Joint Pain. Clinical evaluation centers on serum urate/inflammatory marker in Blood in joint (hemarthrosis) (M25.00: profiling) alongside serial Weight-Bearing Joint Radiograph [Blood in joint (hemarthrosis) M25.00] tracking (Preserved joint-space width (M25.00)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Blood in joint (hemarthrosis) (M25.00) features subchondral bone remodeling [Blood in joint (hemarthrosis) M25.00]. therapeutic stabilization in arthritis & joints is verified against Serum Uric Acid in Blood in joint (hemarthrosis) (M25.00: (Gout Target)).
Common Symptoms & Clinical Signs
- • Presentation of Blood in joint (hemarthrosis) (M25.00): activity-related deep aching in Blood in joint (hemarthrosis) (M25.00: joint pain in)
- • Secondary Blood in joint (hemarthrosis) clinical sign: brief morning joint in Blood in joint (hemarthrosis) (M25.00: stiffness)
- • Symptom flares in Blood in joint (hemarthrosis) correlating with Weight-Bearing Joint Radiograph [Blood in joint (hemarthrosis) M25.00] deviation outside Preserved joint-space width (M25.00)
- • Functional arthritis & joints impact requiring serum urate/inflammatory marker in Blood in joint (hemarthrosis) (M25.00: profiling) evaluation (M25.00)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Blood in joint (hemarthrosis) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M25.00 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoarthritis, Gout & Joint Pain | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Weight-Bearing Joint Radiograph [Blood in joint (hemarthrosis) M25.00] | Preserved joint-space width (M25.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Uric Acid in Blood in joint (hemarthrosis) (M25.00: (Gout Target)) | < 6.0 mg/dL (< 5.0 mg/dL with tophi) (M25.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: hs-CRP & Erythrocyte in Blood in joint (hemarthrosis) (M25.00: Sedimentation Rate) | hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M25.00) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Blood in joint (hemarthrosis)
Treatment selection for Blood in joint (hemarthrosis) depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Blood in joint (hemarthrosis))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Achieved blood pressure and heart and blood vessel outcomes in high-risk: What a 8,407-Participant Study Found Mean achieved SBP less than 120 mm Hg during treatment was associated with increased risk of heart and blood vessel outcomes except for heart attack and stroke. Lancet (London, England) • 2017-06-03 • Meta-Analysis | N = 8,407 | 99/100 | PMID 28390695 ↗ |
| New Insights on Telmisartan and amlodipine single-pill combinations vs amlodipine single-drug: What a 1,097-Participant Study Found Superior BP reductions were also seen with T40-T80/A5 vs A10, with BP goal rates at least as high as with A10; however, there was significantly more peripheral edema with A10 (27.2% vs 4.3% for pooled. Journal of clinical hypertension (Greenwich, Conn.) • 2011-07-15 • Randomized Controlled Trial | N = 1,097 | 96/100 | PMID 21762357 ↗ |
| Check Your Medicine Cabinet: Early Alert: B. Braun Removes Streamline Bloodline Set for Dialog+ The dialyzer connector may not be attached appropriately, resulting in leaking and potential blood loss. FDA MedWatch Safety Alerts • 2026-10-27 • FDA Safety Alert | Multi-cohort | 95/100 | PMID FDA_MEDWATCH-112457955 ↗ |
| Randomized trials of telmisartan vs. Losartan: Which Works Better for Reduction of ambulatory blood pressure? Pooled analysis suggested significant reductions in all of 24-h (MD of systolic/diastolic BP, -2.09/-1.57 mm Hg; 95% CI, -3.39/-2.32 to -0.79/-0.82 mm Hg), last 6-h (-2.96/-2.15 mm Hg; -3.80/-2.72 to -2.13/-1.59 mm Hg),... Hypertension research : official journal of the Japanese Society of Hypertension • 2013-11-15 • Meta-Analysis | N = 2,409 | 94/100 | PMID 23945962 ↗ |
| Randomized trials of telmisartan vs. Valsartan therapy: Which Works Better for Blood pressure reduction? When data from the single-drug treatment and combination therapy (with hydrochlorothiazide) trials were pooled separately, telmisartan therapy was associated with a statistically significant difference in BP reductions... Hypertension research : official journal of the Japanese Society of Hypertension • 2013-07-15 • Meta-Analysis | N = 5,422 | 94/100 | PMID 23344134 ↗ |
Blood in joint (hemarthrosis) Patient Community & “People Like Me” Threads
Filter Blood in joint (hemarthrosis) community threads and patient logs by age, biological sex, dosage, and treatment duration.